Skip to main content

Advertisement

SpringerLink
Log in

Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Sexual dissatisfaction after breast cancer treatment is a common phenomenon that, unfortunately, places a significant strain on young women and is becoming more common as treatment regimens rely more and more on anti-endocrine therapies.

Methods

A PubMed review of peer reviewed manuscripts between the years 1998–2020 evaluating sexual health and wellbeing in cancer patients, primarily young women with breast cancer, was conducted.

Results

There are several categories of sexual dissatisfaction women may experience as a result of her breast cancer diagnosis, including menopausal symptoms and dyspareunia, negative body image, reduced sexual desire, strained relationships and partner communication, and anxiety about cancer disclosure in dating relationships. Several methods of addressing each domain have been studied. While hormonal replacement therapy remains controversial, other medication regimens have been shown to be effective in treating menopausal symptoms and dyspareunia. Cognitive behavioral therapy, sex therapy, and couples’ therapy are all effective in addressing a variety of symptoms across multiple domains.

Conclusions

Oncologists are often not prepared to discuss sexual health concerns as frequently as women need. Further work is needed to bring easily digestible and meaningful educational opportunities into clinical practice so young breast cancer survivors can receive comprehensive post-cancer survivorship care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jeffery DD et al (2015) Self-reported sexual function measures administered to female cancer patients: a systematic review, 2008–2014. J Psychosoc Oncol 33(4):433–466

    PubMed  PubMed Central  Google Scholar 

  2. Carter J et al (2018) Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of cancer care ontario guideline. J Clin Oncol 36(5):492–511

    PubMed  Google Scholar 

  3. Reese JB et al (2017) Effective patient-provider communication about sexual concerns in breast cancer: a qualitative study. Support Care Cancer 25(10):3199–3207

    PubMed  PubMed Central  Google Scholar 

  4. Kedde H et al (2013) Sexual dysfunction in young women with breast cancer. Support Care Cancer 21(1):271–280

    CAS  PubMed  Google Scholar 

  5. Rosenberg SM et al (2013) Body image in recently diagnosed young women with early breast cancer. Psychooncology 22(8):1849–1855

    PubMed  Google Scholar 

  6. Ruddy KJ et al (2013) Young women with breast cancer: a focus group study of unmet needs. J Adolesc Young Adult Oncol 2(4):153–160

    PubMed  PubMed Central  Google Scholar 

  7. Hungr C, Sanchez-Varela V, Bober SL (2017) Self-Image and sexuality issues among young women with breast cancer: practical recommendations. Rev Invest Clin 69(2):114–122

    PubMed  Google Scholar 

  8. Ljungman L et al (2018) Sexual dysfunction and reproductive concerns in young women with breast cancer: Type, prevalence, and predictors of problems. Psychooncology 27(12):2770–2777

    PubMed  PubMed Central  Google Scholar 

  9. Basson R (2000) The female sexual response: a different model. J Sex Marital Ther 26(1):51–65

    CAS  PubMed  Google Scholar 

  10. Oberguggenberger A et al (2017) Self-reported sexual health: breast cancer survivors compared to women from the general population: an observational study. BMC Cancer 17(1):599

    PubMed  PubMed Central  Google Scholar 

  11. Rowland JH et al (2009) Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat 118(1):99–111

    PubMed  PubMed Central  Google Scholar 

  12. Reese JB et al (2016) Adapting a couple-based intimacy enhancement intervention to breast cancer: a developmental study. Health Psychol 35(10):1085–1096

    PubMed  PubMed Central  Google Scholar 

  13. Zhou ES, Falk SJ, Bober SL (2015) Managing premature menopause and sexual dysfunction. Curr Opin Support Palliat Care 9(3):294–300

    PubMed  Google Scholar 

  14. Brotto LA, Yule M, Breckon E (2010) Psychological interventions for the sexual sequelae of cancer: a review of the literature. J Cancer Surviv 4(4):346–360

    PubMed  Google Scholar 

  15. Reese JB, Bober SL, Daly MB (2017) Talking about women's sexual health after cancer: why is it so hard to move the needle? Cancer 123(24):4757–4763

    PubMed  PubMed Central  Google Scholar 

  16. Hickey M et al (2009) Breast cancer in young women and its impact on reproductive function. Hum Reprod Update 15(3):323–339

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Pinto AC (2013) Sexuality and breast cancer: prime time for young patients. J Thorac Dis 5(Suppl 1):S81–S86

    PubMed  PubMed Central  Google Scholar 

  18. Carter J et al (2015) Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program. Support Care Cancer 23(8):2255–2265

    PubMed  PubMed Central  Google Scholar 

  19. Bredart A et al (2011) Prevalence and associated factors of sexual problems after early-stage breast cancer treatment: results of a French exploratory survey. Psychooncology 20(8):841–850

    PubMed  Google Scholar 

  20. Francis PA et al (2018) Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med 379(2):122–137

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Pagani O et al (2014) Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med 371(2):107–118

    PubMed  PubMed Central  Google Scholar 

  22. Bober SL et al (2016) How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care 10(1):44–54

    PubMed  PubMed Central  Google Scholar 

  23. Lammerink EA et al (2012) The management of menopausal symptoms in breast cancer survivors: case-based approach. Maturitas 73(3):265–268

    PubMed  Google Scholar 

  24. Rosenberg SM, Partridge AH (2013) Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis 5(Suppl 1):S55–61

    PubMed  PubMed Central  Google Scholar 

  25. Rosenberg SM et al (2014) Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer 120(15):2264–2271

    PubMed  PubMed Central  Google Scholar 

  26. Melisko ME et al (2017) Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol 3(3):313–319

    PubMed  Google Scholar 

  27. Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped. Lancet 363(9407):453–455

    CAS  PubMed  Google Scholar 

  28. Fahlen M et al (2013) Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer 49(1):52–59

    CAS  PubMed  Google Scholar 

  29. Biglia N et al (2015) Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes? Clin Breast Cancer 15(6):413–420

    PubMed  Google Scholar 

  30. Wurz GT, Soe LH, DeGregorio MW (2013) Ospemifene, vulvovaginal atrophy, and breast cancer. Maturitas 74(3):220–225

    CAS  PubMed  Google Scholar 

  31. Kenemans P et al (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10(2):135–146

    CAS  PubMed  Google Scholar 

  32. Witherby S et al (2011) Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. Oncologist 16(4):424–431

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Dahir M, Travers-Gustafson D (2014) Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy. Sex Med 2(1):8–15

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Anger JT (2017) CO2 laser treatment is effective for symptoms of vaginal atrophy. J Urol 198(6):1228–1229

    PubMed  Google Scholar 

  35. Enemchukwu EA (2017) CO2 laser treatment is effective for symptoms of vaginal atrophy: no. J Urol 198(6):1228–1229

    PubMed  Google Scholar 

  36. Salvatore S et al (2015) Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause 22(8):845–849

    PubMed  Google Scholar 

  37. Cruz VL et al (2018) Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25(1):21–28

    PubMed  Google Scholar 

  38. Administration FAD (2018) FDA warns against use of energy-based devices to perform vaginal 'Rejuvenation' or vaginal cosmetic procedures: FDA safety communication

  39. Anderson DJ et al (2015) Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women's Wellness Program. Menopause 22(9):937–945

    PubMed  Google Scholar 

  40. Langellier KM, Sullivan CF (1998) Breast talk in breast cancer narratives. Qual Health Res 8(1):76–94

    CAS  PubMed  Google Scholar 

  41. Walker HE et al (2016) Perceptions, attributions, and emotions toward endocrine therapy in young women with breast cancer. J Adolesc Young Adult Oncol 5(1):16–23

    PubMed  PubMed Central  Google Scholar 

  42. Seav SM et al (2015) Management of sexual dysfunction in breast cancer survivors: a systematic review. Women's Midlife Health 1(1):9

    PubMed  PubMed Central  Google Scholar 

  43. Hummel SB et al (2017) Efficacy of internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors: results of a randomized controlled trial. J Clin Oncol 35(12):1328–1340

    PubMed  Google Scholar 

  44. Mathias C et al (2006) An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer. Ann Oncol 17(12):1792–1796

    CAS  PubMed  Google Scholar 

  45. Grassi L et al (2018) The use of antidepressants in oncology: a review and practical tips for oncologists. Ann Oncol 29(1):101–111

    CAS  PubMed  Google Scholar 

  46. Clayton AH, Althof S, Kingsberg S, De Rogatis LR, Kroll R, Goldstein I (2016) Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Women’s Health 12(3):325–337

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Badr H et al (2010) Dyadic coping in metastatic breast cancer. Health Psychol 29(2):169–180

    PubMed  PubMed Central  Google Scholar 

  48. Ginter AC, Braun B (2017) Single female breast cancer patients' perspectives on intimate relationships. Qual Health Res 27(10):1461–1472

    PubMed  Google Scholar 

  49. The American Cancer Society Medical and Editorial Content Team (2017) Cancer, sex, and single women. https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/fertility-and-sexual-side-effects/sexuality-for-women-with-cancer/single-woman.html

  50. Breastcancer.org (2019) Single women: finding your way. https://www.breastcancer.org/tips/intimacy/single

  51. Reese JB et al (2019) Patient-clinician communication about sexual health in breast cancer: A mixed-methods analysis of clinic dialogue. Patient Educ Couns 102(3):436–442

    PubMed  Google Scholar 

  52. Albers LF et al (2020) Sexual health needs: how do breast cancer patients and their partners want information? J Sex Marital Ther 46(3):205–226

    CAS  PubMed  Google Scholar 

  53. Eaton AA et al (2017) Validation of clinical tools for vaginal and vulvar symptom assessment in cancer patients and survivors. J Sex Med 14(1):144–151

    PubMed  Google Scholar 

  54. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM, Windschitl HE, Kaur JS, Ellison N (1997) Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 15:969–973

    CAS  PubMed  Google Scholar 

  55. Lee YK et al (2011) Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol 117(4):922–927

    PubMed  Google Scholar 

  56. Goetsch MF, Lim JY, Caughey AB (2015) A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol 33(30):3394–3400

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Caan BJ et al (2012) Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol 30(13):1492–1497

    PubMed  PubMed Central  Google Scholar 

  58. Carson JW et al (2009) Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support Care Cancer 17(10):1301–1309

    PubMed  Google Scholar 

  59. Walker EM et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28(4):634–640

    CAS  PubMed  Google Scholar 

  60. Vincent A et al (2007) Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause 14(1):45–52

    PubMed  Google Scholar 

  61. Loprinzi CL et al (2009) Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27(17):2831–2837

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Goldberg RM, Loprinzi C, O’Fallon JR, Veeder MH, Miser AW, Mailliard JA, Michalak JC, Dose AM, Rowland KMJ, Burnham NL (1994) Transderman clonidine for ameliorating tamoxifen-inuced hot flashes. J Clin Oncol 12:155–158

    CAS  PubMed  Google Scholar 

Download references

Funding

No financial support was used in creation of this manuscript.

Author information

Authors and Affiliations

  1. University of Colorado Cancer Center, Aurora, CO, USA

    Sydney Marsh, Virginia F. Borges, Helen L. Coons & Anosheh Afghahi

Authors
  1. Sydney Marsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia F. Borges
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helen L. Coons
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anosheh Afghahi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anosheh Afghahi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marsh, S., Borges, V.F., Coons, H.L. et al. Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers. Breast Cancer Res Treat 184, 655–663 (2020). https://doi.org/10.1007/s10549-020-05880-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-05880-3

Keywords

Search

Navigation